Gold prices steady, holding sharp gains in wake of soft U.S. jobs data
Investing.com - Atreca reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Atreca announced earnings per share of $-0.600 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.712 on revenue of $0.00.
Atreca 's are down 53.92% and is trading at $1.420 , still down 75.56% from its 52 week high of $5.81 set on Friday, November 12, 2021.
Atreca follows other major Healthcare sector earnings this month
Atreca's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar